Hidradenitis suppurativa, sometimes known as acne inversa or Verneuil's disease, is a long-term dermatological condition characterized by inflamed and swollen lumps that are typically painful and break open, releasing fluid or pus. The areas most commonly affected are the underarms, under the breasts, the perineum, the buttocks, and the groin, and scar tissue remains after healing. The condition may significantly limit everyday activities such as walking, hugging, moving, and sitting, and prolonged sitting can worsen the skin in affected regions.
Facts
Classification
ICD-10 ChapterXII: Diseases of the Skin and Subcutaneous Tissue 1 Communicable or Non-communicable Transmission Route Causative Agent
Causative Agent (category)Idiopathic / Multifactorial 2 First Described Connections
Treated By
Source ChEMBL, EMBL-EBI: Adalimumab approved indications (ChEMBL)
Sources
1. Wikipedia: ICD-10
WikipediaList of chapters, Chapter XIIQuote, List of chapters, Chapter XII
Diseases of the skin and subcutaneous tissue
View the Source 2. Hidradenitis Suppurativa (Wikipedia)
WikipediaBody text, cause statement
The exact cause is usually unclear but believed to involve a combination of genetic and environmental factors.
Infobox: causes
Unknown
View the Source 3. Hidradenitis Suppurativa (Wikipedia)
Lead sectionQuote, Lead section
Hidradenitis suppurativa (HS), sometimes known as acne inversa or Verneuil's disease, is a long-term dermatological condition characterized by the occurrence of inflamed and swollen lumps.
View the Source Wikidata: Hidradenitis Suppurativa
Wikidata Q341999, class allow-list match (w-wdresolver-0926)View the Source ChEMBL, EMBL-EBI: Adalimumab approved indications (ChEMBL)
ChEMBL, EMBL-EBITreated By: Adalimumab, drug_indication record, maximum phase 4, MeSH heading Hidradenitis SuppurativaQuote, Treated By: Adalimumab, drug_indication record, maximum phase 4, MeSH heading Hidradenitis Suppurativa
"max_phase_for_ind": "4.0", "mesh_heading": "Hidradenitis Suppurativa", "molecule_chembl_id": "CHEMBL1201580"
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.